Enhancing Central Nervous System Endogenous GLP-1 Receptor Pathways for Intervention in Alzheimer's Disease

E-ISSN： 1875-5828|2|3|377-385

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.2, Iss.3, 2005-07, pp. : 377-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Crosstalk between Gut Microbiota and Central Nervous System: A Focus on Alzheimer's Disease

Current Alzheimer Research, Vol. 15, Iss. 13, 2018-12 ,pp. : 1179-1190

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling

By Hu Wei

Brain, Vol. 133, Iss. 2, 2010-02 ,pp. : 375-388

Oxford University Press

Access to resources Recommend Favorite

Biomarkers of HIV related central nervous system disease

By Brew Bruce James Letendre Scott Lee

International Review of Psychiatry, Vol. 20, Iss. 1, 2008-02 ,pp. : 73-88

Informa Healthcare

Access to resources Recommend Favorite

Central nervous system disease in patients with macrophagic myofasciitis

By Granel B.

Brain, Vol. 124, Iss. 5, 2001-05 ,pp. : 974-983

Oxford University Press

Access to resources Recommend Favorite

Aberrant Presenilin-1 Expression Downregulates LDL Receptor-Related Protein (LRP): Is LRP Central to Alzheimer's Disease Pathogenesis?

By van Uden E. Carlson G. St. George-Hyslop P. Westaway D. Orlando R. Mallory M. Rockenstein E. Masliah E.

Molecular and Cellular Neuroscience, Vol. 14, Iss. 2, 1999-08 ,pp. : 129-140

Academic Press

Access to resources Recommend Favorite